Strata Critical Medical, Inc.
NASDAQ:SRTAAirlines, Airports & Air Services
-$0.03 today
- Market cap
- $443.03M
- Beta
- 2.20
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.60
Volume 0.99M
Average 0.91M
SRTA Other Non-current Assets
Long-term assets not reported separately.
Strata Critical Medical, Inc.NASDAQ: SRTA
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets rises 1570.6% from a year ago
Other non-current assets stood at $24.29M at the end of Q1 FY2026, up 1570.6% from a year earlier and up 1.1% from the prior quarter. Over 3 fiscal years it compounded at +160.4% a year.
Context
- Other non-current assets amounted to 7.4% of total assets at the end of Q1 FY2026, up 6.8 pp from a year earlier.
- Other non-current assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current assets keeps rising in the next quarterly balance sheet after a +1570.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 24.02M USD
- Year-over-year change
- +1572.5%
- 4-year CAGR
- +219.0%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 24.02M | +1572.5% |
| FY2024 | 2024-12-31 | 1.44M | +2.4% |
| FY2023 | 2023-12-31 | 1.4M | +3.1% |
| FY2022 | 2022-12-31 | 1.36M | +486.2% |
| FY2021 | 2021-09-30 | 232K | — |
Other Non-current Assets vs competitors
How SRTA compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +1570.6% is the highest of 10, against a peer median of +4.1%.
- Other non-current assets amounts to 7.4% of total assets for SRTA, versus a peer median of 1.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $99.29M USD | +23.8% | +43.3% | 16.1% | |
| Mar 2026 | $60.72M USD | +15.5% | +13.1% | 15.8% | |
| Mar 2026 | $53.21M USD | +1.8% | -1.5% | 11.8% | |
SRTAStrata Critical Medical, Inc. | Mar 2026 | $24.29M USD | +1570.6% | +160.4% | 7.4% |
| Mar 2026 | $19.12M USD | +503.7% | +50.7% | 3.5% | |
| Mar 2026 | $9.05M USD | +4.1% | +7.6% | 1.9% | |
| Feb 2026 | $6.88M USD | +11.7% | — | 1.9% | |
| Mar 2026 | $2.05M USD | +2.5% | +27.2% | 0.3% | |
| Apr 2026 | $1.97M USD | -99.0% | +197.1% | 0.1% | |
| Mar 2026 | $210K USD | -95.6% | +15.6% | 0.0% | |
| Mar 2026 | £0 GBP | — | — | 0.0% | |
| Peer median (excluding SRTA) | — | +4.1% | +21.4% | 1.9% | |
Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Sep 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.6M | 41.34M | 27.87M | 18.38M | 30.97M |
| Short-term Investments | 279.37M | 150.74M | 138.26M | 108.76M | 30.26M |
| Net Receivables | 5.55M | 10.88M | 21.01M | 21.59M | 39.96M |
| Inventory | 547K | 0 | 0 | 0 | 0 |
| Other Current Assets | 83K | 3.09M | 19.12M | 12.02M | 25M |
| Total Current Assets | 294.95M | 218.13M | 206.26M | 160.74M | 126.19M |
| Property, Plant & Equipment (Net) | 2.76M | 19.73M | 26.38M | 39.79M | 39.55M |
| Goodwill | 13.33M | 39.45M | 40.37M | 41.05M | 88.21M |
| Intangible Assets | 24.42M | 46.37M | 20.52M | 13.65M | 47.5M |
| Long-term Investments | 200K | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 232K | 1.36M | 1.4M | 1.44M | 24.02M |
| Total Non-current Assets | 40.94M | 106.9M | 88.68M | 95.93M | 199.28M |
| Total Assets | 335.88M | 325.03M | 294.94M | 256.68M | 325.47M |
| Account Payables | 6.37M | 16.54M | 0 | 0 | 19.14M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 6.85M | 6.66M | 0 |
| Other Current Liabilities | 5.98M | 6.71M | 23.86M | 12.77M | 0 |
| Total Current Liabilities | 12.78M | 26.61M | 35.49M | 22.73M | 19.79M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 451K | 185K | 348K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 31.45M | 8.96M | 4.96M | 5.81M | 23.6M |
| Total Non-current Liabilities | 31.73M | 23.93M | 25.15M | 12.01M | 26.61M |
| Total Liabilities | 44.51M | 50.54M | 60.64M | 34.74M | 46.4M |
| Common Stock | 7K | 7K | 7K | 7K | 7K |
| Retained Earnings | (76.42M) | (103.68M) | (159.75M) | (186.9M) | (145.55M) |
| Accumulated OCI | (898K) | 2.29M | 3.96M | 1.75M | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 291.37M | 274.49M | 234.3M | 221.94M | 279.07M |
| Total Debt | 716K | 18.33M | 24.53M | 9.32M | 3.31M |
| Net Debt | (1.88M) | (23.01M) | (3.35M) | (9.06M) | (27.66M) |
Strata Critical Medical, Inc.
NASDAQ:SRTA
Intrinsic Alpha fair value
Locked
Current Price
$4.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.